Comparison of the Prophylactic Action of Flupenthixol with Placebo in Lithium Treated Manic-Depressive Patients

1 June 1986

journal article
research article
Published by Royal College of Psychiatrists in The British Journal of Psychiatry

Vol. 148 (6) , 723-725
https://doi.org/10.1192/bjp.148.6.723

Abstract

A double-blind cross-over trial of depot flupenthixol in recurrent manic depressive psychosis was carried out. Ail patients continued on lithium. Eleven patients completed the two-year trial. Flupenthixol appeared to have no prophylactic effect.

This publication has 13 references indexed in Scilit:

IMMEDIATE INCREASES IN PLASMA PROLACTIN AND NEUROPHYSIN BUT NOT OTHER HORMONES AFTER ELECTROCONVULSIVE THERAPY
The Lancet, 1982
Monitoring the Duration of Electroconvulsive Therapy Seizures
Archives of General Psychiatry, 1982
Neuroendocrine Study of the Mechanism of Action of Electroconvulsive Therapy
Neuropsychobiology, 1982
Flupenthixol decanoate in recurrent manic‐depressive illness
Acta Psychiatrica Scandinavica, 1981
Differential prolactin responses to Haloperidol and TRH in normal adult men
Psychoneuroendocrinology, 1981
Depot Injections for Affective Disorders
The British Journal of Psychiatry, 1980
PROLACTIN RESPONSE TO ELECTROCONVULSIVE THERAPY
The Lancet, 1976
A Double-Blind Comparison of Lithium Carbonate and Maprotiline in the Prophylaxis of the Affective Disorders
The British Journal of Psychiatry, 1976
On Flupentixol, an Antidepressant of a New Chemical Group
The British Journal of Psychiatry, 1969
Behandling af depressive tilstande med Flupentixol
Nordisk Psykiatrisk Tidsskrift, 1966